Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

[Cost effectiveness analysis of screening strategies for cervical cancer in Tunisia].

Lazaar HB, Aounallah-Skhiri H, Oueslati F, Frikha H, Achour N, Hsairi M.

East Mediterr Health J. 2010 Jun;16(6):602-8. French.

PMID:
20799586
2.

[Cost effectiveness of cervical cancer screening strategies in Tunisia].

Hsaïri M, Fakhfakh R, Ghyoula M, Ben Abdallah M, Achour N.

Tunis Med. 2000 Oct;78(10):557-61. French.

PMID:
11190738
3.

Costs and benefits of different strategies to screen for cervical cancer in less-developed countries.

Mandelblatt JS, Lawrence WF, Gaffikin L, Limpahayom KK, Lumbiganon P, Warakamin S, King J, Yi B, Ringers P, Blumenthal PD.

J Natl Cancer Inst. 2002 Oct 2;94(19):1469-83.

PMID:
12359856
4.

Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis.

Karnon J, Peters J, Platt J, Chilcott J, McGoogan E, Brewer N.

Health Technol Assess. 2004 May;8(20):iii, 1-78. Review.

5.

What is the most cost-effective population-based cancer screening program for Chinese women?

Woo PP, Kim JJ, Leung GM.

J Clin Oncol. 2007 Feb 20;25(6):617-24.

PMID:
17308266
6.

[Estimated cost of managing invasive cervical cancer in Tunisia].

Ben Gobrane H, Aounallah-Skhiri H, Oueslati F, Frikha H, Achour N, Hsairi M.

Sante Publique. 2009 Nov-Dec;21(6):561-9. French.

PMID:
20429226
7.

Cost-effectiveness of cervical cancer screening: comparison of screening policies.

van den Akker-van Marle ME, van Ballegooijen M, van Oortmarssen GJ, Boer R, Habbema JD.

J Natl Cancer Inst. 2002 Feb 6;94(3):193-204.

PMID:
11830609
8.

Interactive neural-network-assisted screening. An economic assessment.

Radensky PW, Mango LJ.

Acta Cytol. 1998 Jan-Feb;42(1):246-52.

PMID:
9479347
9.

Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.

Flores Y, Shah K, Lazcano E, Hernández M, Bishai D, Ferris DG, Lörincz A, Hernández P, Salmerón J; Morelos HPV Study Collaborators..

Salud Publica Mex. 2002 Jul-Aug;44(4):335-44.

PMID:
12216521
10.
11.
12.

The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.

Goldie SJ, Weinstein MC, Kuntz KM, Freedberg KA.

Ann Intern Med. 1999 Jan 19;130(2):97-107.

PMID:
10068381
13.

Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.

Kim JJ, Leung GM, Woo PP, Goldie SJ.

J Public Health (Oxf). 2004 Jun;26(2):130-7.

PMID:
15284314
14.
15.
16.

["Cost-effectiveness" of cervical screening].

Kostova P.

Akush Ginekol (Sofiia). 2007;46(6):32-4. Bulgarian.

PMID:
17974169
17.

The cost-effectiveness of cervical screening in Australia: what is the impact of screening at different intervals or over a different age range?

Anderson R, Haas M, Shanahan M.

Aust N Z J Public Health. 2008 Feb;32(1):43-52. doi: 10.1111/j.1753-6405.2008.00165.x.

PMID:
18290913
18.

Costs and effectiveness of alternative strategies for cervical cancer screening in military beneficiaries.

Maxwell GL, Carlson JW, Ochoa M, Krivak T, Rose GS, Myers ER.

Obstet Gynecol. 2002 Oct;100(4):740-8.

PMID:
12383543
19.

Screening for cervical cancer.

Eddy DM.

Ann Intern Med. 1990 Aug 1;113(3):214-26. Review.

PMID:
2115753
20.

Effectiveness and efficiency of opportunistic cervical cancer screening: comparison with organized screening.

Adab P, McGhee SM, Yanova J, Wong CM, Hedley AJ.

Med Care. 2004 Jun;42(6):600-9.

PMID:
15167328

Supplemental Content

Support Center